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 1 
Background: Central nervous system (CNS) infections are an important cause of childhood 1 
morbidity and mortality in high HIV prevalence settings of Africa. We evaluated the 2 
epidemiology of pediatric meningitis in Botswana during the rollout of antiretroviral therapy, 3 
pneumococcal conjugate vaccine (PCV13), and Haemophilus influenzae type B (HiB) vaccine.  4 
Methods: We performed a cross-sectional study of children (<15 years) evaluated for 5 
meningitis by cerebrospinal fluid (CSF) examination from 2000-2015, with complete national 6 
records for 2013-2014. Clinical and laboratory characteristics of microbiologically-confirmed 7 
and culture-negative meningitis were described and incidence of Streptococcus pneumoniae, 8 
Haemophilus influenzae and cryptococcal meningitis estimated for 2013-2014.  9 
Results:  6,796 unique cases were identified. Median age was 1 year (IQR 0-3); 10.4% 10 
(435/4,186) of children with available HIV-related records were known HIV-infected. Overall, 11 
30.4% (2,067/6,796) had abnormal CSF findings (positive microbiological testing or CSF 12 
pleocytosis). Ten-percent (651/6,796) had a confirmed microbiological diagnosis; including 13 
26.9% (175/651) Cryptococcus, 18.9% (123/651) Streptococcus pneumoniae, 20.3% (132/651) 14 
Haemophilus influenzae, and 1.1% (7/651) Mycobacterium tuberculosis. During 2013-2014, 15 
national cryptococcal meningitis incidence was 1.3 cases/100,000 person-years (PYO) 16 
[95%CI:0.8-2.1] and pneumococcal meningitis incidence 0.7/100,000 PYO (95%CI: 0.3-1.3), 17 
with no HiB meningitis diagnosed. 18 
Conclusions: Following HiB vaccination, a marked decline in microbiologically confirmed 19 
cases of Haemophilus influenzae meningitis occurred. Cryptococcal meningitis remains the 20 
most common confirmed etiology, demonstrating gaps in prevention-of-mother-to-child 21 
transmission and early HIV diagnosis. The high proportion of abnormal CSF samples with no 22 
microbiological diagnosis highlights limitation in available diagnostics.  23 
 24 
 25 
 26 
 2 
Background 27 
Meningitis accounts for a substantial burden of disease in children globally.1 Of an estimated 28 
2.8 million meningitis cases in 2016, 54% occurred in children under the age of five, with 46% 29 
of all meningitis deaths in this age group.1 The burden of disease in sub-Saharan Africa is 30 
among the highest globally.1–3 The epidemiology of pediatric meningitis in sub-Saharan Africa 31 
has changed over the past two decades with the evolution of the HIV epidemic, including 32 
interventions for prevention-of-mother-to-child transmission (PMTCT) and antiretroviral 33 
therapy (ART) scale-up, and introduction of vaccines against common bacterial meningitis 34 
pathogens.  35 
 36 
Regional meningitis surveillance data among children <5 years in 24 African countries found 37 
that only 7% of CSF samples reported were culture-positive from 2002-2008.4 The most 38 
commonly confirmed bacterial pathogens were Streptococcus pneumoniae and Haemophilus 39 
influenzae type B, causing 47% and 34% of cases respectively. Meningitis due to Streptococcus 40 
pneumoniae is associated with a 35% in-hospital case-fatality rate (CFR) and Haemophilus 41 
influenzae type B with a 25% CFR among children in Africa, with a high risk of neurological 42 
sequelae a survivors.5 Effective vaccines against Streptococcus pneumoniae and Haemophilus 43 
influenzae type B have been introduced to national immunization programs in sub-Saharan 44 
Africa over the past decades, with a decline in incidence of invasive Streptococcus pneumoniae 45 
and Haemophilus influenzae disease observed in several countries.6–10 46 
 47 
The epidemiology of pediatric cryptococcal meningitis and TB meningitis in high HIV-48 
prevalence African settings is poorly characterized. Early laboratory-based surveillance data 49 
from 2002-2004 in South Africa found that 0.9% of cryptococcal meningitis cases occurred in 50 
children <15 years.11 However, experience from a  referral hospital in Malawi 2000-2012 found 51 
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that cryptococcal meningitis was only observed in children <15 years after 2009, with only a 52 
small proportion of cryptococcal compared to bacterial meningitis cases.12 With maturation of 53 
the HIV epidemic and effective PMTCT, cryptococcal meningitis in children should become 54 
exceedingly rare.  Limited data suggests that TB meningitis, with or without HIV infection, 55 
may be under-recognized. For example, 22% (126/557) of cases of pediatric meningitis 56 
diagnosed at a hospital in Cape Town 2007-2009 were attributed to tuberculosis, although only 57 
10% (13/126) of cases were microbiologically-confirmed.13 Another recent study from South 58 
Africa found that a confirmed CSF microbiological diagnosis was obtained in only 3% 59 
(25/865) of children with suspected TB meningitis from 2010-2014.14  60 
 61 
Botswana, a country in southern Africa with a population of approximately 2 million, has an 62 
adult HIV prevalence of 22.8% in 2017.15 With an effective PMTCT program, in 2015 the 63 
estimated HIV prevalence in children ≤14 years was 2%.15 Botswana has a well-developed 64 
antiretroviral therapy (ART) program that started in 2002, as well as a national electronic 65 
medical record (EMR) system implemented from 2004 onwards.16,17 Childhood HiB 66 
vaccination was introduced nationally in 2011, with the United Nations International 67 
Children’s Emergency Fund (UNICEF) estimating coverage of 96% by 2012.18 Pneumococcal 68 
conjugate vaccine (PCV13) was introduced in July 2012 with estimated 95% coverage by 69 
2014.18 Our primary aim was to describe the epidemiology and temporal trends of meningitis 70 
in Batswana children during the evolution of the local HIV epidemic and vaccine rollout. 71 
72 
 4 
Methods 73 
Data sources. 74 
We used data from the Botswana National Meningitis Survey (BNMS), a national audit from 75 
2000-2015 including all laboratory facilities that analyzed CSF for cases of suspected 76 
meningitis, as previously described.19 Briefly, we scanned paper laboratory records obtained 77 
from in-person visits to all facilities and centrally queried CSF and HIV-related records from 78 
national electronic medical record (EMR) systems. These included Integrated Patient 79 
Management System (IPMS), which started in 2004 at the two national referral hospitals with 80 
gradual rollout to additional facilities, and a national electronic TB registry. Paper records were 81 
entered into a REDcap database and paper and electronic records merged and de-duplicated to 82 
generate a single dataset. Complete CSF data was available for all facilities for 2013-2014, and 83 
compete data was available at both national referral hospitals for 2004-2014.  84 
 85 
Standard CSF evaluation in Botswana throughout the study period included white cell count 86 
(WCC) and differential (if WCC >10 cells/µL), protein and glucose, microscopy (India ink, 87 
Gram stain), bacterial culture with blood and chocolate agar, and fungal culture with Sabouraud 88 
agar. Tuberculous meningitis is evaluated, per ordering clinician request, from Acid-fast 89 
bacillus (AFB) stain (Ziehl-Neelsen), rather than being part of a standard evaluation on all 90 
samples. TB culture is available on request as a send out to a single central TB laboratory. 91 
Gene Xpert MTB/RIF was not performed on CSF. Cryptococcal antigen testing was performed 92 
infrequently using latex agglutination testing (performed on 4% of children during the study 93 
period). Information on HIV status (HIV tests, CD4 count, viral load) was available on a subset 94 
of patients with data in the national EMR. To derive HIV prevalence estimates, any child with 95 
a positive HIV test, documentation of CD4 T-cell count monitoring, and/or HIV viral load 96 
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testing with a detectable viral load was considered to be HIV-infected. National HIV guidelines 97 
recommend HIV-exposed infant screening through PCR evaluation.20  98 
 99 
The study was approved by institutional review boards at the University of Pennsylvania, 100 
University of Washington, University of Botswana, the Ministry of Health’s Health Research 101 
and Development Committee (HDRC), and all hospitals with independent research ethics 102 
committees in Botswana. A waiver of informed patient consent was obtained for retrospective 103 
collection of routine data.  104 
 105 
Data Analysis. 106 
A case was defined as a lumbar puncture (LP) performed on a child aged 0-14 years from 2000-107 
2015 with CSF microbiological testing. Although we did not have clinical data on individual 108 
patients, nearly all LPs in Botswana are performed for evaluation of central nervous system 109 
infection. To exclude repeat LPs, additional LPs from a unique patient within any 14-day 110 
period were excluded. For microbiologically-confirmed tuberculous meningitis, additional LPs 111 
within 180 days were excluded. Patient demographic and laboratory characteristics were 112 
described (using median, interquartile range, and percentages). The cohort was described as a 113 
whole, and further sub-categorised within strata; microbiologically-confirmed (including cases 114 
with a positive gram stain but negative culture) or in cases with negative microbiological work-115 
up - within meaningful WCC strata21; normal (WCC ≤5/µL), mildly abnormal (WCC 6-20/µL), 116 
or markedly abnormal (WCC >20/µL). The markedly abnormal group was further sub-divided 117 
by neutrophil or lymphocyte predominance (neutrophils >50% or ≤50%).  118 
 119 
Cryptococcal meningitis was defined as positive CSF microscopy (gram stain or India ink), 120 
culture, and/or CrAg. Tuberculous meningitis was defined as positive CSF culture for 121 
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Mycobacterium tuberculosis and/or AFB smear. Other organisms were defined through 122 
positive CSF culture.  123 
 124 
Complete CSF records were obtained from all laboratories 2013-2014. Overall population 125 
incidence rates and incidence by category (cryptococcal, pneumococcal and markedly 126 
abnormal CSF) were calculated using UNAIDs population denominators, stratified by age. 127 
Poisson distribution was used to calculate 95% confidence intervals.  128 
 129 
For the time period from 2004-2014, when full CSF laboratory records were available at the 130 
two national referral hospitals, the number of cases of pneumococcal, cryptococcal, and 131 
Haemophilus influenzae meningitis in children were plotted by year to evaluate temporal trends 132 
and crude overall trends over time were assessed using unadjusted Poisson regression. 133 
Microbiologically confirmed cases of Haemophilus influenzae were plotted by month of 134 
diagnosis to look for seasonal trends (Supplementary material). Analyses were performed in 135 
Stata (Version 14, College Station, TX) and the ggplot2 package in R.22  136 
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Results 137 
Overall description of cases.  138 
7,238 CSF samples were analysed from children aged 0-14-years between 2000 and 2015. 139 
After excluding repeat samples, 6,796 unique episodes were observed in 6,508 children (Figure 140 
1). Median age was 1 year (IQR 0-3) and 53.7% (3,647) of episodes occurred in males. HIV-141 
related data was available from the EMR for 61.6% (4,186) of children; of those, 10.4% 142 
(435/4,186) were known to be HIV-positive.  143 
 144 
From 2000-2015, 9.6% (651/6,796) of CSF samples yielded a positive microbiological 145 
diagnosis (Table 1). Cryptococcus was the most common etiology, observed in 26.9% 146 
(175/651) of microbiologically-confirmed cases. Median age of children with Cryptococcus 147 
was 5 years (IQR 1-10, Supplementary Figure 1) and 57.7% (97/175) were male. Minimal CSF 148 
inflammatory changes were noted in Cryptococcus (median WCC 2/µL [IQR 2-33]) and 100% 149 
(108/108) of children with data on HIV status were positive.  150 
 151 
Among bacterial pathogens, Haemophilus influenzae was cultured in 20.3% (132/651) of 152 
microbiologically-confirmed cases. Median age of children with Haemophilus influenzae was 153 
1 year (IQR 0-2) and 52.9% (65/132) were male. CSF was markedly abnormal, with a median 154 
WCC of 1480/µL (IQR 246-2000) and 10.1% (7/69) of children with data on HIV status were 155 
positive.  156 
 157 
Culture-confirmed Streptococcus pneumoniae accounted for 18.9% (123/651) of 158 
microbiologically-confirmed cases, with a median age of 3 years (IQR 0-7) and 55.3% (63/123) 159 
male. CSF was markedly abnormal for pneumococcal meningitis, with a median WCC of 160 
420/µL (IQR 120-2000), with neutrophil predominance and 30.2% (16/53) of children with 161 
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data on HIV status were known positive. A further 63 cases had gram stain showing gram 162 
positive cocci but negative cultures (Supplementary Table 1). Fifteen cases of Streptococcus 163 
agalactiae and 45 cases of meningitis caused by gram negative rods were observed 164 
(Supplementary Table 2). 165 
 166 
Tuberculous meningitis was diagnosed in 1.1% (7/651) of microbiologically-confirmed cases, 167 
with a median age of 3 years (IQR 1-7) and a majority diagnosed by CSF Mycobacterium 168 
tuberculosis culture (5/7) and 2 by AFB stain. CSF TB evaluation was uncommon: culture was 169 
performed in 2.9% (198/6,796) of cases and AFB smear in 14.4% (975/6,796). Other 170 
uncommon culture-positive pathogens are included the footnote of Table 2.  171 
 172 
Ninety percent (6,145/6,796) of children investigated with LP had no microbiologically-173 
confirmed diagnosis (Table 1). Of these, 17.2% (1,055/6,145) had no WCC recorded. Of cases 174 
with a recorded WCC, 11.7% (595/5,090) had mildly abnormal (WCC 6-20/µL) and 16.1% 175 
(821/5,090) markedly abnormal (WCC >20/µL) CSF. Of cases with markedly abnormal CSF, 176 
49.5% (406/821) were lymphocyte-predominant, 35.6% (292/821) neutrophil-predominant, 177 
and the remainder had no differential cell count. 178 
 179 
National incidence from 2013-2014 and temporal trends at referral hospitals.  180 
National incidence estimates were calculated during 2013-2014 (Table 2). Among children 181 
aged 0-14-years an estimated 91.0 LPs were performed per 100,000 person-years of 182 
observation (PYO) [95%CI:86.2-96.1]. Highest incidence was observed in the 0-4 age group 183 
with 222.3 LPs/100,000 PYO (95%CI:209.4-235.8). Restricted to cases with positive 184 
microbiology findings (smear, culture, and/or CrAg), the overall meningitis incidence for 185 
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children was 5.4 cases/100,000 PYO (95%CI:4.3-6.7). Highest incidence was observed in the 186 
0-4-year age group at 10.5/100,000 PYO (95%CI:6.9-12.4).  187 
 188 
Estimated incidence of culture-confirmed pneumococcal meningitis was 0.7/100,000 PYO 189 
(95%CI:0.3-1.3) for all children. Incidence was highest in the 0-4-year and 5-9-year groups at 190 
0.6 (95%CI:0.1-1.8) and 1.0 (95%CI:0.3-2.4) per 100,000 PYO, respectively. Estimated 191 
incidence of cryptococcal meningitis was 1.3/100,000 PYO (95%CI:0.8-2.1). Incidence was 192 
highest in the 0-4-year group at 2.0/100,000 PYO (95%CI:1.0-3.7). Using 2013-2014 UNAIDS 193 
estimates of the number of HIV-positive children in Botswana and assuming all cryptococcal 194 
meningitis cases occurred in HIV-positive children, HIV-associated incidence was 54/100,000 195 
PYO (95%CI:32.5-84.2). 196 
 197 
Cases of Haemophilus influenzae declined between 2004-2014 at referral hospitals (p=0.02), 198 
with no cases observed from year 2013 onward (Figure 2). A decline was not observed for 199 
cryptococcal (p=0.19) or pneumococcal cases (p=0.22). Seasonal trends observed for 200 
Haemophilus influenzae included a higher number of cases in colder months with lower rainfall 201 
(Supplementary Figure 2). 202 
  203 
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Discussion 204 
 205 
Using a large, nationally representative sample of almost 7,000 children (aged 0-14-years) 206 
being investigated for suspected meningitis over a 16-year period in Botswana, we have 207 
described the epidemiology and evolution of pediatric meningitis in a high HIV-prevalence 208 
region in sub-Saharan Africa. Although Haemophilus influenzae accounted for over 20% of 209 
microbiologically-confirmed cases of meningitis over the 16-year study period, a marked 210 
decline was observed following introduction of HiB vaccination, with only two 211 
microbiologically-confirmed cases after vaccine introduction in 2011 and none from 2013 212 
onward. Declines in incidence of H. influenzae meningitis have also been observed in other 213 
African settings. 23–26 Strikingly, despite over a decade of ART scale-up in Botswana and a 214 
successful PMTCT program, Cryptococcus remained the most common confirmed etiology of 215 
paediatric meningitis through 2013-2014. During this period, we observed an incidence of 1.3 216 
cases per 100,000 PYO in children aged 0-14-years and an HIV-associated incidence of 54 217 
cases per 100,000 PYO. This is just over half the incidence rate observed in HIV-positive adults 218 
in Botswana.19 219 
 220 
Whilst the importance of Haemophilus influenzae and Streptococcus pneumoniae as causative 221 
organisms in pediatric meningitis in the region have been well described,4 Cryptococcus is not 222 
usually considered a major causative organism in pediatric meningitis in sub-Saharan Africa. 223 
Population-based laboratory surveillance data from urban Gauteng Province, South Africa 224 
showed a similar incidence of cryptococcal meningitis in HIV-infected children to that 225 
observed in our study (47 per 100,000 PYO in 0-14-year olds) despite this prior surveillance 226 
data being over a decade earlier before ART was available (2002-2004).27 Data from a 227 
pediatrics hospital in Cape Town, South Africa from 2007-2009 reported Cryptococcus in 228 
<0.2% of cases (1/557), with a similar HIV prevalence in this population of 8%.13 More recent 229 
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pediatric data from a single center in Ivory Coast from 2012-2013 found cryptococcal 230 
meningitis accounted for 6.5% (2/31) of microbiologically-confirmed meningitis cases, but the 231 
small sample limits inference.23 The high relative incidence observed in Botswana likely has 232 
to do,  in part, with excellent case ascertainment with standard India ink stain and fungal culture 233 
testing on all CSF samples. We found that there was a peak in cryptococcal meningitis in the 234 
youngest age group (Supplementary Figure 1). This early-onset cryptococcal meningitis almost 235 
certainly represents disease in immunosuppressed infants following mother-to-child 236 
transmission of HIV, with a lower ongoing incidence of cryptococcal meningitis occurring in 237 
children either not diagnosed in infancy or failing ART. Botswana has a successful prevention 238 
of mother-to-child transmission (PMTCT) program;15 however, the continued presence of 239 
cryptococcal meningitis highlights the challenges of achieving full coverage.  240 
 241 
The incidence of pneumococcal meningitis observed in 2013-2014 was 0.7 per 100,000 PYO 242 
(95% CI 0.3-1.3). This is a minimum estimate as we restricted incidence analysis to culture-243 
confirmed cases. Furthermore, Botswana did not use polymerase chain reaction (PCR) or other 244 
advanced diagnostics that might increase diagnostic yield.28 These rates are three-fold higher 245 
than the estimated incidence of 0.25 cases per 100,000 PYO in children aged 1-17-years in the 246 
United States in 2010.29 No obvious decline was seen in the two years following the role out 247 
of the PCV13 vaccination, although it is unclear what proportion of the susceptible population 248 
was vaccinated during this period. Further surveillance and ideally pneumococcal serotyping 249 
of isolates is needed to evaluate the impact of childhood pneumococcal vaccination and 250 
potential emergence of serotypes not targeted by PCV13.  251 
 252 
We obtained a microbiological diagnosis in only a small proportion (9.6%) of children 253 
evaluated for meningitis, with an additional 20.8% (1,416/6,796) having raised CSF white cell 254 
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counts but no pathogen identified. This is similar to other studies in sub-Saharan Africa 255 
investigating meningitis in children; with 3.7% of LPs revealing a microbiological diagnosis 256 
in a study from the Ivory Coast23, 7% in Mozambique,30 and 17% in Angola.24 The low yield 257 
can be attributed to a number of factors. Particularly in the neonatal period, LP is frequently 258 
performed as part of a sepsis screen, when suspicion for clinical meningitis may be low. 259 
However, the large number of cases with markedly abnormal CSF but negative microbiological 260 
studies suggests that there were a large number of undiagnosed infections and highlights an 261 
urgent need for improved diagnostics to guide therapeutic management including availability 262 
of PCR to assess common bacterial and viral pathogens and tailor therapy.31 Other factors 263 
contributing to the low microbiological testing yield include a proportion of children with 264 
bacterial meningitis who were pre-treated with antibiotics before LP, resulting in sterile 265 
culture.32  266 
 267 
Botswana has a high TB incidence, 33 so we would have expected to find more TB meningitis 268 
cases, suggesting that TB meningitis was significantly underdiagnosed. A number of factors 269 
likely contribute to the low number of confirmed TB meningitis cases; CSF culture and 270 
microscopy have low sensitivity, particularly in children.34 However, more importantly, only 271 
3% of children had CSF sent for TB culture and only 14% of samples were evaluated by AFB 272 
stain. Six percent (406/6,797) of CSF samples had elevated white cell counts with lymphocyte 273 
predominance, some of which are likely attributable to TB. A study in Cape Town, South 274 
Africa - with similar HIV epidemiology - reported 2.3% (13/557) of pediatric CSF samples 275 
were TB culture-positive, significantly higher than observed in our study (0.10% [7/6,796)]).13 276 
Using an expanded definition of TB (CSF with high protein, low glucose, lymphocyte 277 
predominance and two clinical characteristics suggestive of TB) 22% of cases were attributed 278 
to TB.13 As a laboratory-based surveillance study, we are unable to determine the number of 279 
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children who are treated empirically for TB, but improved TB diagnostic testing to guide 280 
therapy should be prioritized including expanded use of PCR-based testing (e.g. XPert 281 
MTB/RIF) and culture.35 282 
 283 
Our study had some important limitations. Firstly, we had incomplete HIV-related details, 284 
limited to data available in the EMR. However, for 61% of children in the study with electronic 285 
records, 10% were known HIV-infected which is substantially higher than general population 286 
prevalence estimates for children ≤14-years in Botswana (2%).15 It is unlikely that many HIV-287 
exposed but uninfected infants would have been misclassified as HIV-infected due to serologic 288 
testing detecting residual maternal antibody as national guidelines recommend PCR testing 289 
rather than serology for HIV diagnosis in exposed infants.20 Secondly, our data was limited to 290 
routinely-collected laboratory data, meaning detailed clinical information was unavailable. 291 
Information on treatment given, outcomes, ART status, and immunization and nutritional status 292 
were not available. Thirdly, age in children was generally recorded as a whole number (e.g. 0 293 
years, 1 year); therefore, neonatal meningitis could not be clearly delineated from meningitis 294 
later in the first year of life.  295 
 296 
In conclusion, our study has shown a reduction in Haemophilus influenzae meningitis 297 
following the national roll out of the vaccine. Conversely, pneumococcal meningitis cases 298 
remained common throughout the study period, and further surveillance is needed to assess the 299 
impact of childhood pneumococcal vaccination. The high incidence of cryptococcal meningitis 300 
reflects gaps in the PMTCT program; effective PMTCT, with detection of exposed infants and 301 
appropriate case management and early initiation of treatment of infants who go onto develop 302 
HIV is central to reducing this high incidence. Importantly, the low proportion of cases with 303 
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microbiological confirmation highlight the urgent need for enhanced diagnostics to guide 304 
appropriate clinical management and prevention strategies.  305 
306 
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Table 1. Clinical and laboratory characteristics of children 0-14 years evaluated for meningitis from 2000-2015 
Pathogen 
Age 
(years), 
median 
(IQR) 
Sex (male), 
% (n)  
CSF WCC 
(/µL), median 
(IQR)b 
Lymphocytes, 
% (IQR) 
 
 
Neutrophil  
% (IQR) 
Protein 
(g/dL), 
median 
(IQR) 
Glucose 
(mmol/L), 
median 
(IQR) 
HIV 
positive, % 
(n)c 
All non-TB bacteriald (n=468) 1 (0-4) 56.2 (243) 443 (70-2000) 10 (5-24) 
90 (76-95) 
2.9 (1.5-5.2) 0.4 (0.1-1.7) 14.5 (36) 
Streptococcus pneumoniae (n=123) 3 (0-7) 55.3 (63) 420 (120-2000) 10 (5-20) 
90 (80-95) 
3.5 (2.0-5.8) 0.1 (0.0-1.0) 30.2 (16) 
Haemophilus influenzae (n=132) 1 (0-2) 52.9 (65) 1480 (246-2000) 10 (4-20) 
90 (80-96) 
2.4 (1.1-3.9) 0.4 (0.1-1.2) 10.1 (7) 
TB (n=7) 3 (1-7) 57.1 (4) 140 (10-270) 60 (30-90 
40 (10-70) 
 --- --- 50.0 (1) 
Cryptococcus (n=175) 5 (1-10) 57.7 (97) 2 (2-33) 90 (55-96) 
10 (4-45) 
0.6 (0.3-1.7) 2.5 (1.8-3.4) 100.0 (108) 
CSF WCC 0-5 (n=3,674) 1 (0-2) 56.8 (2,002) 2 (0-2) 75 (35-96) 
 
25 (4-65) 0.4 (0.2-0.8) 3.7 (3.0-4.6) 7.3 (179) 
CSF WCC 6-20 (n=595) 0 (0-2) 61.4 (337) 10 (8-15) 90 (65-98) 
 
10 (2-35) 0.7 (0.3-1.1) 3.3 (2.5-4.6) 5.6 (20) 
CSF WCC >20 lymphocyte 
predominant (n=406) 1 (0-5) 55.0 (210) 125 (45-400) 90 (78-95) 
 
10 (5-22) 1.5 (0.7-2.6) 2.2 (1.1-3.1) 12.0 (32) 
CSF WCC >20 neutrophil 
predominant (n=292) 1 (0-7) 48.9 (134) 322 (90-1843) 15 (5-30) 
 
85 (70-95) 1.8 (1.0-3.0) 1.8 (0.8-2.8) 9.9 (16) 
IQR = interquartile range; WCC = white cell count 
a missing data on sex for 5.2% (347) of sample 
b Upper limit recorded for WCC of 2000/µL 
c missing data on HIV status for 38.4% (2,610) of sample, HIV prevalence stated represents prevalence among those with available HIV status data 
d positive bacterial culture (346) or gram stain (122) [excluding Mycobacterium tuberculosis]. Culture positive: 132 Haemophilus influenza, 123 Streptococcus pneumoniae, 15 streptococcus agalactiae, 12 Salmonella 
Spp, 12 Staphylococcus aureus, 9 Escherichia coli, 9 Klebsiella pneumoniae, 7 coagulase negative Staphylococcus, 7 Pseudomonas Spp. 2 Enterobacter Spp, 1 Listeria monocytogenes, 1 Neisseria meningitides, 1 
Proteus mirabilis, 15 other or unidentified and 62 gram positive cocci, 43 gram negative rods, 12 gram negative cocci, 5 gram positive rods. 
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Table 2. 2013-2014 National incidence of meningitis in children 0-14 years in Botswana  
Strata Agea (years) Number of cases Person Years 
Incidence (95%CI) (per 
100,000 person-years) 
Underwent meningitis 
evaluation by lumbar 
punctures 
0-14 1319 1,449,341 91.0 (86.2-96.1) 
 0-4 1101 495,308 222.3 (209.4-235.8) 
 5-9 118 481,331 24.5 (20.3-29.4) 
 10-14  1100 472,702 21.2 (17.2-25.7) 
Any abnormal CSF 
(WCC >20µL or non-
Cryptococcus pathogen 
identified) 
0-14 171 1,449,341 11.8 (10.1-13.7) 
 0-4 117 495,308 23.6 (19.5-28.3) 
 5-9 28 481,331 5.8 (3.9-8.4) 
 10-14  26 472,702 5.5 (3.6-8.1) 
Any microbiological 
diagnosis (excluding 
Cryptococcus)b 
0-14 78 1,449,341 5.4 (4.3-6.7) 
 0-4 52 495,308 10.5 (7.8-13.8) 
 5-9 16 481,331 3.3 (1.9-5.4) 
 10-14  10 472,702 2.1 (1.0-3.9) 
Streptococcus 
pneumoniae 
0-14 10 1,449,341 0.7 (0.3-1.3) 
 0-4 3 495,308 0.6 (0.1-1.8) 
 5-9 5 481,331 1.0 (0.3-2.4) 
 10-14  2 472,702 0.4 (0.1-1.5) 
Cryptococcus 
0-14 19 1,449,341 1.3 (0.8-2.1) 
 0-4 10 495,308 2.0 (1.0-3.7) 
 5-9 4 481,331 0.8 (0.2-2.1) 
 10-14  5 472,702 1.1 (0.3-2.5) 
CI = confidence interval; WCC = white cell count 
a Three percent of cases from 2013 and 2014 did not have documented age. It was assumed the distribution of ages in those with no documented age was the same as those who had age documented. Samples missing age 
were allocated to different age categories in these proportions. For example, if 10% of cryptococcus cases occurred in children aged 0-15 then 10% of samples missing age were allocated to the 0-15 age group.  
b Microbiological diagnosis= positive CSF microscopy (gram stain or AFB) or culture excluding any confirmed cryptococcal cases 
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Figure 1. Cerebrospinal fluid findings from 6,796 cases of suspected meningitis in children 0-14 years 
 
 
CSF = cerebrospinal fluid; TB = tuberculosis; WCC = white cell count 
* Microbiological diagnosis = positive CSF microscopy (gram stain, India ink or AFB), culture or CrAg 
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Figure 2. Trends in meningitis cases in children aged 0-14 years at two national referral hospitals from 2004-2014 (arrows showing roll out of 
vaccination against haemophilus and pneumococcus) 
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Supplementary table 1. Clinical and laboratory characteristics of children 0-14 years with Streptococcus pneumoniae meningitis diagnosed by 
culture only and using composite definition of culture or gram positive cocci on gram stain without positive culture 
Pathogen 
Age 
(years), 
median 
(IQR) 
Sex 
(male), % 
(n)  
CSF WCC 
(/µL), median 
(IQR)b 
Lymphocyte, 
% (IQR) 
 
 
 
Neutrophi
l % (IQR) 
Protein 
(g/dL), 
median 
(IQR) 
Glucose 
(mmol/L), 
median (IQR) 
HIV 
positive, 
% (n)c 
Culture-positive only (n=123) 3 (0-7) 51.2 (63) 420 (120-2000) 10 (5-20) 90 (80-95) 3.5 (2-5.8) 0.1 (0.0-1.0) 30.2 (16) 
Composite definitiond (n=186) 2 (0-7) 48.4 (90) 410 (90-2000) 10 (5-20) 90 (80-95) 3 (2-5.8) 0.3 (0.1-1.2) 24.3 (18) 
 
IQR = interquartile range; WCC = white cell count 
a missing data on sex for 5.2% (347) of sample 
b Upper limit recorded for WCC 2000/µL 
c missing data on HIV status for 38.4% (2,610) of sample 
d Composite definition = positive culture or gram positive cocci 
 
 
 
Supplementary table 2. Clinical and laboratory characteristics of children 0-14 years with Streptococcus agalactiae and gram negative rod   
meningitis 
Pathogen 
Age 
(years), 
median 
(IQR) 
Sex 
(male), 
% (n)  
CSF WCC 
(/µL), median 
(IQR)b 
Lymphocytes, 
% (IQR) 
 
 
 
Neutrophil 
% (IQR) 
Protein 
(g/dL), 
median 
(IQR) 
Glucose 
(mmol/L), 
median 
(IQR) 
HIV 
positive, 
% (n)c 
Streptococcus agalactiae (n=15) 0 (0-0) 73 (11) 1180 (50-2000) 10 (5-20) 90 (80-95) 3.9 (2.0-4.4) 1.3 (0.8-2.4) 0.0 (0) 
Gram negative rodsd (n=88) 0 (0-1) 56.6 (47) 200 (20-2000) 10 (5-29) 90 (71-95) 2.4 (0.9-6.3) 0.3 (0.1-2.3) 12.1 (7) 
 
IQR = interquartile range; +ve = positive; WCC = white cell count 
a missing data on sex for 5.2% (347) of sample 
b Upper limit recorded for WCC 2000/µL 
c missing data on HIV status for 38.4% (2,610) of sample 
d Gram negative rod=gram negative rod on gram stain or culture of gram negative rod organism 
 24 
Supplementary figure 1: Histogram of distribution of ages for a) all cases, b) Cryptococcus, c) Pneumococcus and d) Haemophilus 
a)                                                                     b) 
   
c)                                                                     d) 
  
 
 
 
 
 
 25 
Supplementary Figure 2: (A) Culture-confirmed Haemophilus influenzae meningitis cases, 
(B) average rainfall (centimeters), and (C) average temperature (Celsius) by month 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Average monthly temperature and rainfall in Botswana calculated 2000-2015. Source: World Bank Group – Climate Change 
Knowledge Portal. Available at: https://climateknowledgeportal.worldbank.org/country/botswana 
a) 
b)  
c)  
     
 
